title: Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?
authors.affiliation: Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. carlos.grijalva@vanderbilt.edu
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Grijalva
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Moore
authors.forename: Marie R
authors.initials: MR
authors.lastname: Griffin
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D032521:Immunity, Herd; D008297:Male; D011008:Pneumococcal Infections / Q000276:immunology*; D022242:Pneumococcal Vaccines / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000276:immunology*
chemical_list: D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines